Media Coverage

Merial, Boehringer launch needle-free canine vaccine


Feb 12, 2018 - Animal Pharm
By Sian Lazell 
Animal Pharm
February 12, 2018


Merial has added to its canine vaccine portfolio with Recombitek Oral Bordetella. 

The firm – now part of Boehringer Ingelheim –  has launched the oral vaccine against against canine infectious tracheobronchitis caused by Bordetella bronchiseptica in the US.

Recombitek Oral Bordetella is administered via the dog's buccal cavity (inside the cheek). Merial said clinical studies suggest as a mucosal vaccine, it offers dogs a robust immune response after a single dose.

B bronchiseptica is one of the leading pathogens responsible for canine infectious respiratory disease complex. Signs of infection include coughing, sneezing, nasal and/or ocular discharge, lethargy and loss of appetite. In severe cases, the condition can advance to lower respiratory disease, such as pneumonia, and even result in death.

Merial explained B bronchiseptica is unique as it can evade the immune system for weeks or even months. During this time, a dog that is infected can be exposing other dogs to the pathogen without showing signs of illness.

Frank Capella, a veterinarian at Village Veterinary Hospital in Canastota, New York, said: "Because of the disease's common name, 'kennel cough', people may think it's a disease only kenneled animals can get. But it causes a highly contagious disease spread through social contact. Many dogs are at risk. Vaccination by a veterinarian remains the first line of defense."

Zach Mills, executive director of Boehringer Ingelheim's US pet vet veterinary professional services, added: "For many dogs, oral delivery may mean a less stressful experience without the unpleasant sneeze backs of alternative vaccines delivered through the nose. The packaging's flip-top vial cap allows for easy opening by veterinary staff and the safe, needle-free pipette simplifies the vaccination process while reducing risk of injury."

Merial's Recombitek line also includes vaccines against lyme disease, canine distemper, canine parvovirus, canine parainfluenza, canine coronavirus and canine leptospirosis.

Reprinted with permission of Animal Pharm News

Share

Search

Archive

News Releases

Inside the Corridor

KC Animal Health Blog

Investment Forum